Skip to main content
Log in

Clinical pharmacology in Europe: An indispensible part of the health service

  • Report
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Clinical Pharmacology (1970) Scope, organization, training. Report of a WHO Study Group. WHO Tech Rep Ser No 446, WHO, Geneva

    Google Scholar 

  2. Clinical Pharmacological Services (1977) Report of a Working Group. WHO, Regional Office for Europe, Copenhagen

    Google Scholar 

  3. Dukes MNG (1984) The seven pillars of follishness. In: Dukes MNG (ed) Side-effects of drugs. Elsevier, Amsterdam

    Google Scholar 

  4. Taylor D, Griffin J (1985) Does Britain spend too much on pharmaceuticals? Pharm J 234: 228–230

    Google Scholar 

  5. Alván G, Öhman B, Sjöqvist F (1983) Problem-oriented drug-information: A clinical pharmacological service. Lancet II: 1410–1412

    Google Scholar 

  6. Rawlins MD (1984) Postmarketing surveillance of adverse reactions to drugs. Br Med J 288: 879–880

    Google Scholar 

  7. Bergman U, Wiholm B-E (1981) Drug related problems causing admission to a medical clinic. Eur J Clin Pharmacol 20: 193–200

    Google Scholar 

  8. Anonymous (1985) What therapeutic drugs should be monitored? Lancet 2: 309–310

  9. American Psychiatric Association (1985) Tricyclic antidepressants — blood level measurements and clinical outcome: An APA Task Force Report. Am J Psychiatry 142: 155–162

    Google Scholar 

  10. Breckenridge A, Orme M, Serlin MJ, Davidson AS, Lowe JF (1978) Postgraduate education in therapeutics: experience in Merseyside. Br Med J 2: 671–672

    Google Scholar 

  11. Brodie BB (1964) Of mice, microsomes and man. Pharmacologist 6: 12–26

    Google Scholar 

  12. Eichelbaum M (1982) Defective oxidation of drugs: Pharmacokinetic and therapeutic implications. Clin Pharmacokinet 7: 7–22

    Google Scholar 

  13. Principles for the Clinical Evaluation of Drugs (1968) Report of a WHO Scientific Group. WHO Tech Rep Ser, No. 403, WHO, Geneva

    Google Scholar 

  14. Guidelines for Evaluation of Drugs for Use in Man (1975) Report of a WHO Scientific Group. WHO Tech Rep Ser, No. 563, WHO, Geneva

    Google Scholar 

  15. Bergman U, Grimsson A, Wahba AHW, Westerholm B (eds) (1979) Studies in drug utilization. WHO, Regional Office for Europe, Copenhagen

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Additional information

Members: J. Bircher (Switzerland, at present FRG), M. Bogaert (Belgium), M.N.G.Dukes (WHO, Europe), M.Eichelbaum (FRG), L.F.Gram (Denmark), H.Hüller (DDR), M. Orme (UK), F.Sjöqvist, Chairman (Sweden), G.Tognoni (Italy)

Rights and permissions

Reprints and permissions

About this article

Cite this article

WHO Working Group on Clinical Pharmacology in Europe., Sjöqvist, F. Clinical pharmacology in Europe: An indispensible part of the health service. Eur J Clin Pharmacol 33, 535–539 (1988). https://doi.org/10.1007/BF00542483

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00542483

Key words

Navigation